AdvanCell Commences Drug Product Manufacture from its Facility in Queensland, Australia News AdvanCell Commences Drug Product Manufacture from its Facility in Queensland, AustraliaAdvanCell Commences Drug Product Manufacture from its Facility in Queensland, Australia October 8th, 2024, SYDNEY…DesignQ Developer8 October 2024
AdvanCell Recognised in Good Design Award Australia 2024 News AdvanCell Recognised in Good Design Award Australia 2024AdvanCell Recognised in Australia’s International Good Design Awards for Excellence in Design and Innovation September…DesignQ Developer20 September 2024
UroToday: Oliver Sartor MD interviews AdvanCell CMO Anna Karmann MD PhD on the current state and future of radiopharmaceuticals and the advantages of Lead-212 News UroToday: Oliver Sartor MD interviews AdvanCell CMO Anna Karmann MD PhD on the current state and future of radiopharmaceuticals and the advantages of Lead-212Source: UroToday Lead-212 Radiopharmaceuticals: Advancing Targeted Alpha Therapy in Oncology - Anna Karmann Oliver Sartor…DesignQ Developer30 August 2024
First-in-Human 212Pb-PSMA–Targeted α-Therapy SPECT/CT Imaging in a Patient with Metastatic Castration-Resistant Prostate Cancer Presentations/Publications First-in-Human 212Pb-PSMA–Targeted α-Therapy SPECT/CT Imaging in a Patient with Metastatic Castration-Resistant Prostate CancerSource: AdvanCell First-in-Human 212Pb-PSMA–Targeted α-Therapy SPECT/CT Imaging in a Patient with Metastatic Castration-Resistant Prostate Cancer There…DesignQ Developer29 February 2024
AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer News AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical OfficerAdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer January 4, 2024 - SYDNEY,…DesignQ Developer4 January 2024
AdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of ²¹²Pb-ADVC001 in Metastatic Prostate Cancer News AdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of ²¹²Pb-ADVC001 in Metastatic Prostate CancerAdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of 212Pb-ADVC001 in Metastatic…DesignQ Developer8 November 2023
AdvanCell Announces Flagship Facility News AdvanCell Announces Flagship FacilityAdvanCell Announces the Launch of its Flagship Facility to Support Global Scaled Manufacture of Targeted…DesignQ Developer3 November 2023
AdvanCell Delivers ²¹²Pb-ADVC001 to the Peter MacCallum Cancer Centre News AdvanCell Delivers ²¹²Pb-ADVC001 to the Peter MacCallum Cancer CentreAdvanCell delivers 212Pb-ADVC001, a development stage Targeted Alpha Therapy for Prostate Cancer to the Peter…DesignQ Developer7 September 2023
AdvanCell a Successful Recipient of the CRC Project Selection Round News AdvanCell a Successful Recipient of the CRC Project Selection RoundSource: Cooperative Research Centre Projects (CRC-P) GrantsCRC Projects selection round outcomes Cooperative Research Centres Projects…DesignQ Developer30 June 2023
Advancell awarded a $9.8M in federal funding News Advancell awarded a $9.8M in federal fundingSource: Australian Government Ministers Department of Health and Aging$73 million for new medical technology and…DesignQ Developer27 June 2023